Skip to content

Inspection Record

American Red Cross Biomedical Sevices Headquarters — FDA 483 Findings

US FDAInspected 2015-08-12Published 2024-01-17 4 findingsOther quality systemDeviation, CAPA, and investigation

View the regulator's official source The source document is always the basis for judgement.

Findings

1Other quality system

The American Red Cross Biomedical Services failed to promptly investigate, correct, and pre ven t ?

2Other quality system

The American Red Cross Biomedical Services failed to submit 48 hour consigned notifications as req uired in Par agraph X.E.

3Other quality system

The American Red Cross Biomedical Services failed to promptly investigate, correct, and prevent ?

4Deviation, CAPA, and investigation

American Red Cross Biomedical Services failed to submit biological product deviations (BPDs) within 45 days as requ ired in Paragraph X.D.

A record as of the US FDA document published on 2024-01-17. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.

American Red Cross Biomedical Sevices Headquarters company profile — full historyAll US FDA findings US FDA documents, 2024 Go to Findings search
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.